Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialtypharmaceutical and drug delivery company, today announced thatmanagement will host a conference call to discuss first quarter 2006results and provide a business update on Wednesday, May 10, 2006, at10:00 A.M. EDT. Bentley will release results for the three monthsended March 31, 2006, before the open of the market on that day.
To participate on the live call, please dial (888) 332-7254 fromthe U.S. and Canada or, for international callers, please dial (973)582-2856 (access code 7347553), approximately 10 minutes prior to thescheduled start time. A telephone replay will be available for 30 daysby dialing (877) 519-4471 from the U.S. and Canada or (973) 341-3080for international callers (please reference reservation number7347553). The conference call will also be broadcast live on theInternet and may be accessed via Bentley's web site,www.bentleypharm.com. Please go to the Company's web siteapproximately 10 minutes prior to the scheduled start time toregister. A replay of the conference will also be available onBentley's web site for 30 days.
Bentley Pharmaceuticals, Inc. is a specialty pharmaceuticalcompany focused on advanced drug delivery technologies andpharmaceutical products. Bentley's proprietary drug technologiesenhance or facilitate the absorption of pharmaceutical compoundsacross various membranes. Bentley also manufactures a growingportfolio of generic and branded pharmaceuticals in Europe for thetreatment of cardiovascular, gastrointestinal, infectious andneurological diseases through its subsidiary, Laboratorios Belmac, andmarkets these pharmaceutical products through its subsidiaries,Laboratorios Belmac, Laboratorios Davur, Laboratorios Rimafar andBentley Pharmaceuticals Ireland; and manufactures and markets activepharmaceutical ingredients through its subsidiary, Bentley API.
Copies of Bentley Pharmaceuticals' press releases and otherinformation may be obtained through Bentley's web site atwww.bentleypharm.com.
